A candidate for spine loss in Parkinson’s disease is CaN (also known as PP2B), whose excessive activation activates the signalling pathways of MEF2 and cofilin as well as leucine-rich repeat kinase 2 (Lrrk2), which results in spine shrinkage and loss. This evidence concerns the gene LRRK2 and Parkinson disease.